Articles |
From Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata (Argentina).
Correspondence to Dr Horacio E. Cingolani, Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Calle 60 y 120, 1900 La Plata, Argentina.
| Abstract |
|---|
|
|
|---|
Key Words: myocardial pHi Na+-H+ exchange Na+-independent Cl-/HCO3- exchange spontaneously hypertensive rats BCECF
| Introduction |
|---|
|
|
|---|
The hyperactivity of the Na+-H+ exchanger could result in a rise of both pHi and [Na+]i. The increase in [Na+]i would lead to a secondary increase in [Ca2+]i via the Na+-Ca2+ exchanger. The activity of Na+-H+ exchanger has been widely studied in different cell types in experimental and human hypertension with a variety of results.6 7 8 9 10 11 12 13 However, measurements of pHi in hypertrophied myocardium are scanty.14 15
The present study reports a hyperactivity of the Na+-H+ exchanger in the myocardium of the SHR and elucidates the mechanism by which the alteration is offset under physiological conditions.
| Materials and Methods |
|---|
|
|
|---|
Solutions
The muscles were superfused with one of the following solutions:
(1) HEPES-buffered solution containing (mmol/L) NaCl 133.8, KCl 4.5,
CaCl2 1.35, MgSO4 1.05, glucose 11, and HEPES
25 (the pH of the buffer solution [pHo] was adjusted to
7.38±0.03 at 30°C with 3N NaOH [total Na+ amounted to
148.8 mmol/L], and the solution was gassed with 100% O2);
(2) HCO3-/CO2-buffered
solution, which contained (mmol/L) NaCl 128.3, KCl 4.5,
CaCl2 1.35, NaHCO3 20.23,
NaH2PO4 0.35, MgSO4 1.05, and
glucose 11 (the solution was equilibrated with
CO2/O2 gas mixture to ensure a
PCO2 value of 35 mm Hg at the chamber level,
with the pHo of
HCO3-/CO2-buffered
solutions being 7.37±0.01 at 30°C); (3) Na+-free
HCO3-/CO2-buffered
solution in which 20.23 mmol/L NMG was substituted for
NaHCO3 and in which NaCl and
NaH2PO4 were replaced with an equimolar amount
of choline chloride (saturation of the solution with 5%
CO2/95% O2 gave a pH of 7.38±0.01).
The Na+-H+ exchanger was inhibited with 5
µmol/L EIPA (RBI). Anion exchanger mechanisms were inhibited by SITS
(Sigma Chemical Co) added to the superfusate (final
concentration, 0.1 mmol/L).
pHi Measurements
Muscles were loaded with the ester form of the pH-sensitive
fluorescent dye BCECF (Molecular Probes). The dye was
solubilized in dimethyl sulfoxide (Sigma Chemical Co) containing
pluronic acid F-127 (20% [wt/vol]) and diluted to a final
concentration of 5 µmol/L in
HCO3-/CO2-buffered
solution. After autofluorescence levels were recorded,
the muscles were incubated for
3 hours in the BCECF-AMcontaining
solution. At the end of the loading period, fluorescence was
uniformly distributed throughout the muscle, and it amounted to about
four to five times the autofluorescence level. In
BCECF-AMloaded cells, it has been reported that most of the
fluorescence arises from cytoplasmic-located BCECF,
therefore making the potential error in pHi measurements
due to compartmentation relatively small.18 Since our
experiments lasted several hours, loading of intracellular organelles
was assessed in four papillary muscles at the end of the experimental
protocol. The cell membrane was permeabilized with 15
µmol/L digitonin to induce the release of cytosolic BCECF.
Afterwards, 1% Triton X-100 was applied. The data obtained from the
decrease in fluorescence at 450-nm excitation wavelength showed
that
60% to 64% of the fluorescent probe was in the
cytosol, in agreement with previous reports in cardiac
tissue.19 20 During the loading process,
contractility decreased by
40% to 50%, but it
gradually recovered during the washout. Washout of the extracellular
space with dye-free solution was carried out for 90 minutes before
any pHi determination was done.
To measure fluorescence emission from BCECF, excitation light from a 75-W Xenon lamp was band-passfiltered alternatively at 450 and 495 nm and was then transmitted to the muscles under study by a dichroic mirror (reflecting wavelengths, <510 nm) located beneath the microscope. Fluorescence emission was collected by the microscope objective (x10) and transmitted through a band-pass filter at 535±5 nm to a photomultiplier (model R2693, Hamamatsu). The output of the photomultiplier, together with the force transducer signals, was collected via an A/D converter (model 2801 A, Data Translation) and stored in a personal computer for later analysis. To limit photobleaching, a neutral density filter (1% transmittance) was placed in the excitation light path, and a manual shutter was used to select sampling intervals (2 seconds every 10 seconds) during the protocol. At the end of each experiment, fluorescence emission was calibrated by exposing the muscles to a high-KCl solution containing 10 µmol/L nigericin, a H+-K+ exchanger that equals [H+]o to [H+]i when extracellular and intracellular K+ are the same. The calibration solution contained (mmol/L) KCl 140.0, MgCl2 1.0, CaCl2 1.35, HEPES 5.0, sodium cyanide 4, and BDM 20.0 to prevent muscle contracture.18 Buffer pH was adjusted with KOH or HCl to four different values ranging from 7.5 to 6.5. Such a calibration revealed a linear relation (r=.99±.001, n=39) between pH and the fluorescence ratio (F495/F450) calculated as follows: ratio=(fluorescence at 495 nm-autofluorescence at 495 nm)/(fluorescence at 450 nm-autofluorescence at 450 nm). Within this range of pH values, the "in vivo" calibrations could be superimposed with calibrations of BCECF-free acid solutions. This makes unlikely the possibility that the fluorescence signals could have been distorted by incomplete hydrolysis of the sequestered dye within intracellular organelles (see above). The fluorescence ratio was not altered when either EIPA (5 µmol/L) or SITS (0.1 mmol/L) was added to the bath during the calibration.
Calculation of Intracellular Buffering Power and Net H+
or HCO3- Fluxes
JH+ and JHCO3- were
estimated from the rate of pHi recovery
(dpHi/dt) after an intracellular acid or alkali
load, respectively. Alkali load was imposed by rapidly exposing the
muscles to TMA hydrochloride.21 Ten-minute pulses of
different TMA concentrations (10, 20, or 30 mmol/L) were applied
without osmotic compensation, and the values of
dpHi/dt were determined as the change in
pHi observed during the first minute after the peak
alkalosis. Intracellular acidification was induced by switching from
HEPES-buffered superfusate to the
CO2/HCO3--buffered
one. The values of pHi during the recovery phase from the
acid load values were fitted to an exponential curve of the form
pHit=
pHi
(1-e-k
t),
where
pHit and
pHi
are the changes in
pHi from the initial value at time t and after steady state
has been reached, respectively, and k is the rate
coefficient. From this curve fit, values of dpHi/dt
(change in pHi per minute) for each experiment were
calculated. The following equation was used for calculation of net
JH+ or JHCO3-
(mmol/L/min):
JH+/HCO3-=ßtotxdpHi/dt,
where ßtot was calculated as the sum of intrinsic buffer
capacity (ßi) plus the buffering power due to
intracellular
CO2/HCO3-
(ßCO2). ßCO2 was considered to be 2.3 times
[HCO3-]i, assuming
an open system for CO2 and that its solubility and pK value
are the same at either side of the cell membrane.
[HCO3-]i at any given
pHi was calculated from the Henderson-Hasselbalch equation
to be
[HCO3-]i=[HCO3-]ox10(pHi-pHo).
ßi was calculated from the change in
[HCO3-]i produced by
exposing the preparations to CO2 as
ßi=
[HCO3-]i/
pHi
observed when HEPES-buffer superfusate was switched to
CO2/HCO3-
buffer.22
[HCO3-]i was considered
to equal the value of
[HCO3-]i during the
exposure to CO2, since in the absence of external
CO2, the value of
[HCO3-]i is very low (
50
µmol/L23 ). The main problem for estimating
ßi is that acid extrusion during the loading period may
blunt the acidosis, thus leading to overestimation of ßi
value (see Reference 2222 for details). To reduce errors due to acid
extrusion, we (1) blocked the Na+-H+ exchanger
with 5 µmol/L EIPA 20 minutes before the acid load and (2)
extrapolated the pHi recovery back to a point where it
intersected the line defining the maximum initial rate of acid loading.
Both methods (ie, blockade and backextrapolation) have been used in
previous works,24 25 26 27 28 and they are an attempt to correct
the errors in the estimation of ßi due to
Na+-H+ exchange or any other H+
extruder mechanism. In the absence of Na+-H+
exchange blockade, using only the backextrapolation method, the
estimated values of ßi were 57.78±4.62 mmol/L at a mean
pHi of 6.99±0.01 in SHR (n=7) and 46.33±6.50 mmol/L in
WKY rats (pHi 6.89±0.05, n=5) (P=NS). After
EIPA blockade and also by use of the backextrapolation method,
ßi values of 57.18±6.99 at pHi 6.89±0.03 in
SHR (n=5) and 45.98±5.53 in WKY rats (pHi 6.85±0.04, n=4)
(P=NS) were estimated. The fact that the values of
ßi estimated by the backextrapolation method were not
significantly decreased after Na+-H+ exchange
blockade suggested that the backextrapolation alone was enough to
reduce errors. However, since it was suggested that the
backextrapolation method does not always make an adequate
correction,28 the values estimated in the presence of EIPA
blockade plus backextrapolation were used in the present study. No
statistically significant difference in ßi was detected
between the myocardium of both strains. Actually, higher
values of ßi were determined in the
myocardium of SHR. If this were a real difference, we would
be underestimating ion fluxes in the myocardium of SHR.
Statistics
Data are presented as mean±SEM. Statistical
analysis was performed by using either a paired t
test or Student's t test, as appropriate. A value of
P<.05 was considered significant.
| Results |
|---|
|
|
|---|
|
|
When the myocardium was exposed to HEPES buffer bubbled
with oxygen (nominally bicarbonate free), pHi was higher in
SHR than in WKY rats, as shown in Fig 1
. In HEPES
buffer, myocardial pHi in the normotensive rats was
7.10±0.04, a value in agreement with previous reports in this
species.29 In the SHR, however, mean pHi was
significantly higher (7.23±0.03, P<.05). Since the
estimation of cellular buffer capacity showed no significant difference
between the myocardium of both rat strains (see
"Materials and Methods") and proton production is
unlikely decreased in the SHR, the only mechanism that could account
for the increased myocardial pHi of the SHR was an enhanced
H+ extrusion (or acid equivalent). Under nominally
bicarbonate-free conditions, the main mechanism extruding
H+ from the cell is presumably the
Na+-H+ exchanger.30 Even though
the existence of a lactate/proton carrier in the heart cell membrane
has been demonstrated, its contribution to the maintenance of
steady state pHi seems to be negligible, since specific
inhibition of the transporter does not alter the steady state value of
pHi.20 31 Therefore, the simple finding of the
higher value of pHi in HEPES buffer strongly suggested a
hyperactivity of the exchanger in the hypertrophic
myocardium of the SHR. This was confirmed in additional
experiments in which inhibition of bicarbonate-dependent regulatory
pHi mechanisms by SITS (0.1 mmol/L) did not change
myocardial pHi in SHR (7.26±0.03 and 7.28±0.03 before and
20 minutes after SITS administration, respectively; n=3). This is
important, since a small contribution of bicarbonate-dependent
mechanisms even in the absence of bicarbonate in the perfusate
was recently described.32
|
If the higher steady state pHi of SHR
myocardium in HEPES buffer were the result of a hyperactive
Na+-H+ exchanger, the blockade of the
antiporter should minimize the difference in pHi between
both strains. This is shown in Fig 2
, which illustrates
that the inhibition of the antiporter with EIPA decreased myocardial
pHi to a greater extent in SHR than in WKY rats. Twenty
minutes after treatment with EIPA, pHi decreased by
0.16±0.01 pH unit in SHR (n=6) versus a decrease of 0.09±0.02 in WKY
rats (n=5) (P<.05). The difference in steady state
myocardial pHi was then minimized when the
Na+-H+ exchanger was blocked. These data
suggested that in spite of the higher pHi, the
Na+-H+ exchanger was operating at a higher
activity level in SHR. It can be argued that the greater decrease in
pHi induced by EIPA in SHR was the result of a higher
proton production. However, the higher steady state myocardial
pHi of SHR in the absence of EIPA makes this possibility
very unlikely.
|
The difference in myocardial pHi detected between SHR and
WKY rats in HEPES buffer was not detected when a
bicarbonate/CO2 buffer was used. In
HCO3-/CO2 media,
myocardial pHi levels in SHR and WKY rats were 7.15±0.03
and 7.11±0.05, respectively (P=NS) (Fig 1
).
This finding suggested that a bicarbonate-dependent mechanism(s)
operating in the hypertensive rat was fully compensating for the
increased activity of the Na+-H+ exchanger.
This could be accomplished by mechanism(s) that was carrying either
HCO3- out of the cells or H+
into the cells.
The possibility of an enhanced activity of the
Cl--HCO3- exchanger in
SHR was explored by assessing the effect of SITS on steady state
myocardial pHi in the presence of
bicarbonate/CO2 buffer. Fig 3
shows typical
tracings obtained on one muscle from each rat strain. The increase in
pHi induced by SITS in SHR clearly contrasted with the lack
of effect in WKY rats. On average, the increase in pHi
induced by SITS was 0.08±0.02 pH unit (P<.05 by paired
t test, n=3) in SHR, whereas no significant change was
detected in WKY rats (0.04±0.04, n=3). The increase in pHi
induced by SITS in SHR suggested that the blocker was suppressing a
mechanism that was extruding HCO3- from
the cell in this rat strain. This evidence together with the
minimization of the differences in myocardial pHi between
hypertensive and normotensive rats under bicarbonate buffer is in favor
of the role played by the enhanced activity of the
Cl--HCO3-
exchanger.
|
Fig 4
shows the changes in myocardial pHi
observed when the HEPES-buffered superfusate was changed to
HCO3-/CO2 buffer, at
constant pHo. After the initial fall induced by
CO2 permeation, pHi gradually recovered,
although the driving force cannot explain a passive
HCO3- influx. Considering that the
equilibrium potential for HCO3- ions
varied between -35 mV (at the time of peak acidosis) and
-20 mV (after pHi recovery) and estimating a membrane
potential value of
-80 mV, the equilibrium potential for
HCO3- ions was more positive than the
membrane potential during the whole recovery period, indicating a net
outward driving force for HCO3- ions.
Therefore, mechanisms extruding H+ (or the acid equivalent)
have to be considered in order to explain the recovery in
pHi.
|
Although the initial pHi was higher in HEPES buffer in SHR, the fall in pHi induced by the introduction of the bicarbonate/CO2 buffer was similar in both rat strains (0.24±0.03 pH unit in SHR and 0.21±0.04 pH unit in WKY rats). This is consistent with the fact that the myocardium of both strains had similar buffer capacities. However, the different pHi values at the beginning of the recovery preclude the comparisons of the initial velocity of recovery (dpHi/dti). When the velocity of pHi recovery (dpHi/dt) of the myocardium of both rat strains was compared at a common pHi value of 6.99, a faster rate of recovery was found in SHR. In SHR, dpHi/dt (in pH units per minute) was 0.068±0.02 (n=7), whereas it was 0.014±0.002 (n=6, P<.05) in WKY rats. The enhancement of the rate of proton extrusion in SHR myocardium after the acid load became negligible when the Na+-H+ exchange was blocked by EIPA was 0.0032±0.002 in SHR (n=5) and 0.0032±0.002 in WKY rats (n=4).
Since the acid-extruding mechanisms are modulated by
pHi, net H+ (or acid equivalent)
extrusion was estimated as a function of pHi. As explained
in "Materials and Methods," JH+ equal
to ßtotxdpHi/dt and the
estimated values plotted as a function of pHi in SHR and
WKY rats are shown in Fig 5
. This plot allowed us to
compare the H+ extrusion at a given pHi in the
myocardium of the two strains of rats. It is evident that
for a given pHi, H+ extrusion was
greater in the myocardium of the SHR than in the WKY rat;
ie, JH+ amounted to 1.58±0.49 mmol/L per
minute in SHR and 0.35±0.07 mmol/L per minute in WKY rats at
pHi 7.05 (P<.05). The slopes of the lines
relating JH+ and pHi in the
myocardium of both strains were different
(-17.46±1.05 in SHR and -7.39±0.33 in WKY rats,
P<.05). The lines relating JH+ and
pHi fitted to an equation of the form
JH+=-17.46xpHi+124.61 mmol/L
per minute in SHR and JH+
=-7.39xpHi+52.43 mmol/L per minute in WKY rats. The
larger differences in JH+ were detected at the
more acidic values of pHi, but the difference in
JH+ progressively vanished as the increase in
pHi took place. This fact is providing additional evidence
of the enhanced activity of the antiport in the myocardium
of SHR.
|
Since the Na+-independent
Cl--HCO3- exchanger is
the only bicarbonate-dependent mechanism able to acidify the cell
and since it is stimulated by increases in pHi, the
possible role played by this exchanger in regulating myocardial
pHi in the SHR was explored. To test the activity of this
anion exchanger, the heart muscles from both rat strains were
alkalinized with TMA as described in "Materials and Methods," and
the recoveries during the alkaline load were compared. In each of three
muscles from SHR and from WKY rats, three different pulses of TMA were
performed. Fig 6
shows digitized values of
pHi obtained during a TMA pulse on one muscle from SHR and
one muscle from WKY rats (top panel). The dpHi/dt
during TMA pulses was measured as
pHi observed during
the first minute after the peak of alkalosis, as illustrated by the
broken lines. The bottom panel of Fig 6
shows the
individual nine results obtained in both rat strains. It can be noted
that the recovery from different alkaline loads was more evident in the
myocardium from SHR than in the myocardium from
WKY rats. Furthermore, when the comparison was made between runs in
which pHi increased to similar values, a lesser increase in
pHi seemed to be necessary to drive the anion exchanger in
the myocardium of the hypertensive animals. At a mean
pHi value of 7.49±0.06, dpHi/dt in SHR
was 0.075±0.028 pH unit/min (P<.05, n=3), whereas no
significant recovery could be detected in WKY rats (0.027±0.017 pH
unit/min, n=3). The enhanced velocity of pHi recovery in
SHR was suppressed after SITS. When the alkaline load induced by the
TMA pulse was performed after the blockade of the anion exchanger with
0.1 mmol/L SITS, no significant recovery in myocardial pHi
was detected. At a pHi value of 7.41±0.04,
dpHi/dt was 0.024±0.013 pH unit/min in SHR (n=3,
P=NS). At a similar pHi (7.47±0.13),
dpHi/dt was 0.004±0.03 pH unit/min
(P=NS) in WKY rats (n=3).
|
From the data of pHi recovery during the alkaline
load, the relation between net HCO3-
efflux (or acid equivalent) (JHCO3-) and
pHi was estimated, and the data obtained are shown in Fig 7
. The line relating JHCO3- to
pHi was shifted leftward, intercepting the x
axis at lower pHi values in SHR (7.25±0.04) than in WKY
rats (7.43±0.06) (P<.05), indicating that the
bicarbonate-dependent mechanism responsible for the recovery from
alkalosis was operative at lower pHi values in the
myocardium of SHR than WKY rats. The slopes of the lines
were not different, since
JHCO3-=27.40xpHi-196.94
mmol/L per minute in SHR, and
JHCO3-=26.28xpHi-193.84
mmol/L per minute in WKY rats. At a given pHi then, during
alkalosis the myocardium from SHR seems to extrude more
HCO3- than does the
myocardium from WKY rats. The electroneutral exchange of
Cl- for HCO3- across
the membrane of vertebrate cells is a nearly ubiquitous transport
mechanism that has been extensively studied in Purkinje
fibers33 and in isolated cardiac myocytes.21
The two main characteristics of this system are its Na+
independence and its activation at pHi values above resting
pHi. To check our hypothesis about the involvement of the
Cl--HCO3- exchanger in
regulating pHi in SHR, it was necessary to probe the
enhanced activity of this exchanger under Na+-free
conditions. The recoveries from alkalosis under Na+-free
conditions in experiments similar to those described in Fig 6
were compared in four muscles from SHR and in four
from WKY rats. Fig 8
shows tracings from a typical
experiment in one muscle from a hypertensive rat. For comparison, the
results observed when the myocardium was challenged with
the same alkaline load in the presence of extracellular Na+
are also shown. It is evident that under Na+-free
conditions, a marked recovery from the alkaline load was detected. When
the rate of pHi recovery from the alkaline load was
compared between SHR and WKY rats, a faster recovery was again detected
in SHR. At mean pHi of 7.30, dpHi/dt was
0.051±0.02 pH unit/min in SHR (n=4), whereas it amounted to only
0.0195±0.003 pH unit/min in WKY rats (n=4) (P<.05).
Therefore, the data support the hypothesis of an enhanced activity of
the Na+-independent anion exchanger in the
myocardium from hypertensive rats.
|
|
| Discussion |
|---|
|
|
|---|
A still unanswered question in the present study is whether the hyperactivity of the Na+-H+ exchanger that we detected is a characteristic of the hypertensive animals or of the hypertrophic myocardium itself. Further experiments are necessary to dissect hypertension from hypertrophy in order to elucidate this problem. In connection with this, a recent study by de la Sierra et al5 showed that an increased Na+-H+ exchange and decreased Na+-K+-Cl- cotransport activities in erythrocytes from patients with essential hypertension were significantly correlated with left ventricular mass, independent of the blood pressure levels.
Cellular growth and the effects of growth factors are known to be linked to intracellular alkalinization via stimulation of the Na+-H+ exchanger.34 35 Na+-H+ hyperactivity in hypertension can account for the observed increases in [Na+]i36 and can also provide a molecular basis for cellular growth, particularly if it is accompanied by a decrease in Na+ pump activity.37 The fact that in the presence of physiological bicarbonate buffer, no significant changes in myocardial pHi were detected in our experiments cannot be argued to deny an increase in [Na+]i due to the hyperactivity of Na+-H+ exchange. The increase in [Na+]i can still be present even if the effect of the hyperactivity of Na+-H+ exchange on pHi was blunted by the enhanced activity of the Cl--HCO3- exchanger. The increase in [Na+]i will lead to an increase in [Ca2+]i via the Na+-Ca2+ exchanger. The increase in [Ca2+]i could be a signal for promoting cellular growth by activation of protein kinase C and/or protooncogene induction.38
The possibility of an enhanced activity of the Na+-H+ exchanger has been widely explored in several blood cell types from hypertensive humans and animals.6 7 8 9 10 11 12 13 In vivo studies suggest a hyperactivity of the Na+-H+ exchanger in skeletal muscle of hypertensive patients39 and SHR.40 We are aware of two studies in which measurements of myocardial pHi were performed in hypertensive or hypertrophic rats.14 15 Neither of these studies showed changes in steady state pHi in the hypertensive animal, but we have to consider that these studies were not designed to study the possible hyperactivity of the exchanger and that both of them were performed with bicarbonate/CO2 buffer. As we mentioned before, an increased activity of the Na+-independent Cl--HCO3- exchanger will blunt the increase in pHi.
Although our data report for the first time the enhanced activity of the Na+-H+ exchanger in the myocardium of the SHR, we do not elucidate the cellular mechanism for the enhanced exchanger activity. In a recent study,41 a polyclonal serum specific for NHE-1 was raised in the rabbit and was used to study NHE-1 expression in cultures of vascular and skeletal myocytes from SHR and WKY rats and also from extracts of crude membrane from hearts. No significant changes in the amount of NHE-1 protein were detected in SHR cells relative to WKY cells. These data and others showing more extensive phosphorylation of the exchanger13 42 suggest that the increased activity results from an increased turnover number per Na+-H+ exchanger molecule.
An enhanced Na+-H+ exchange activity may be the
result of an increased intracellular H+ activity, induced
either by a diminished buffer capacity or by an increased proton
generation. These possibilities seem to be unlikely since (1) no
significant differences in buffer capacities were detected between the
normotensive and hypertensive animals, in accordance with previous
findings,11 41 and (2) in the SHR, the steady state
myocardial pHi in HEPES buffer was higher and not lower, as
would be expected if proton production were increased. However,
an overcompensation of an increased H+ production
by an hyperactive antiporter is a possibility to be considered. In
addition, the data displayed in Fig 5
show that at any
given pHi, JH+ is greater in
the hypertensive than in the normotensive rat.
It has been postulated that changes in [Ca2+]i are linked to changes in Na+-H+ exchange activity, with the rise in [Ca2+]i being the primary cause of enhanced Na+-H+ exchange activity.43 44 However, [Ca2+]i has to be elevated far beyond the values found in hypertension to induce an activation of the antiport.45 An increased activity of PKC would also induce hyperactivity of the Na+-H+ exchanger.46 Although no evidence of altered PKC activity in essential hypertension has yet been provided,13 it looks attractive if the possibility of an overexpression of tissue angiotensin-converting enzyme resulting in angiotensin-mediated hypertrophy47 is considered. In this regard, it may be of interest that multiple clinical studies have suggested that pharmacological inhibition of angiotensin-converting enzyme may be superior to other blood pressurelowering interventions for inducing regression of cardiac hypertrophy.48
A very interesting finding in the present study was that the
increased activity of the myocardial Na+-H+
exchanger was masked by the enhanced activity of the
Na+-independent
Cl--HCO3- exchanger.
This electroneutral exchange of intracellular
HCO3- for extracellular
Cl- across the plasma membrane of vertebrate cells
was first described in erythrocytes.49 It has been
extensively studied in cardiac muscle (for further references, see
Reference 3333 ), and it has been implicated in the defense against alkali
load. This exchanger appears to be activated only at
pHi above resting values.33 Although we do not
know of any study involving this exchanger in myocardium
from hypertensive animals, it is interesting that an enhanced activity
of the transporter has been detected in red blood cells from
hypertensive patients.50 The authors hypothesized that the
decreased pHi of red blood cells from hypertensive subjects
was the result of the enhanced activity of this anion exchanger. It is
evident from our data that pHi has to surpass values of
7.4 in order to detect HCO3- efflux in
the myocardium of the WKY rats. However, lower
pHi values were inducing significant
HCO3- efflux in the
myocardium of SHR. The cellular mechanisms by which the
hypertensive rat (or the hypertrophic myocardium) is
presenting an increased activity of this anion exchanger
accompanying the enhanced activity of the
Na+-H+ exchange is not apparent to us. The
driving force for this exchanger results from an inward gradient for
Cl- exceeding that for
HCO3- under normal conditions. If we
assume constant extracellular ionic concentrations and constant
membrane potential, either a decrease in intracellular
Cl- or an increase in intracellular
HCO3- would increase the activity of the
exchanger. An increased
[HCO3-]i with the resulting
increase in pHi could result from an enhanced activity of
the Na+-H+ exchanger. However, our data
comparing the activity of the anion exchanger in the
myocardium from normotensive and hypertensive rats at
similar values of pHi do not support this possibility. The
enhanced activity of the anion exchanger in SHR seems to be independent
of changes in pHi. We are not aware of reports about a
decrease in intracellular Cl- in hypertension that
could explain the hyperactivity of this exchanger.
In conclusion, we report an increased activity of the Na+-H+ exchanger in the hypertrophic myocardium of the SHR. This hyperactivity of the antiporter is not a consequence of a decreased pHi, and it is masked under physiological conditions in which the HCO3-/CO2 buffer is used, by the Na+-independent Cl--HCO3- anion exchanger. The role played by an enhanced anion exchanger activity compensating the hyperactive Na+-H+ exchanger is based on the following pieces of evidence: (1) Steady state myocardial pHi in SHR was higher than in WKY rats under nominally bicarbonate-free conditions, but the difference diminished in the presence of HCO3-/CO2 buffer. (2) The blockade of bicarbonate-dependent mechanisms by SITS increased steady state pHi only in SHR. (3) Challenging the anion exchanger with an alkaline load (TMA pulse) induced a recovery in pHi significantly faster in SHR than in WKY rats, and this difference was not detected after SITS blockade. (4) The enhanced recovery of myocardial pHi in the SHR after an alkaline load was Na+ insensitive.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received December 30, 1994; accepted August 28, 1995.
| References |
|---|
|
|
|---|
2.
Post WS, Larson MG, Levy D. Impact of left
ventricular structure on the incidence of hypertension: the
Framingham Heart Study. Circulation. 1994;90:179-185.
3. de la Sierra A, Coca A, Pare JC, Sobrino J, Sanchez M, Paz MA, Jimenez V, Urbano-Marquez A. Clinical profile of essential hypertensives based on ion-transport abnormalities: preliminary results. J Hypertens. 1991;9(suppl 6):S308-S309.
4. Strazzullo P, De Simone G, Celentano A, Iacone R, Ragone E, Pagano E, Tammaro P, Canessa M. Sodium-hydrogen exchange and cardiac hypertrophy in patients with primary hypertension. J Hypertens. 1991;9(suppl 6):S306-S307.
5.
de la Sierra A, Coca A, Pare JC, Sanchez M, Valls V,
Urbano-Marquez A. Erythrocyte ion fluxes in essential
hypertensive patients with left ventricular
hypertrophy. Circulation. 1993;88:1628-1633.
6.
Tepel M, Klaus T, Laukemper S, Zidek W. Reduced
sodium proton exchange activity in lymphocytes from transgenic
rats. Hypertension. 1994;24:357-361.
7.
Redon J, Batlle D. Regulation of intracellular
pH in the spontaneously hypertensive rat: role of
bicarbonate-dependent transporters.
Hypertension. 1994;23:503-512.
8.
Resnik LM, Gupta RK, Sosa RE, Corbett ML, Laragh
JH. Intracellular pH in human and experimental
hypertension. Proc Natl Acad Sci U S A. 1987;84:7663-7667.
9. Orlov SN, Postnov IY, Pokudin NI, Kukharenko VY, Postnov YV. Na+/H+ exchange and other ion-transport systems in erythrocytes of essential hypertensives and spontaneously hypertensive rats: a comparative analysis. J Hypertens. 1989;7:781-788. [Medline] [Order article via Infotrieve]
10. Ng LL, Dudley C, Bomford J, Hawley D. Leukocyte intracellular pH and Na+/H+ antiport activity in human hypertension. J Hypertens. 1989;7:471-475. [Medline] [Order article via Infotrieve]
11. Ng LL, Fennell DA, Dudley C. Kinetics of the human leukocyte Na+/H+ antiport in essential hypertension. J Hypertens. 1990;8:533-537. [Medline] [Order article via Infotrieve]
12. Goldsmith DJA, Tribe RM, Poston L, Cappuccio FP, Markandu ND, MacGregor GA, Hilton PJ. Leukocyte intracellular pH and Na+/H+ exchange activity in essential hypertension: an in vitro study under physiological conditions. J Hypertens. 1991;9:645-653. [Medline] [Order article via Infotrieve]
13. Livne AA, Aharonovitz O, Paran E. Higher Na+/H+ exchange rate and more alkaline intracellular pH set-point in essential hypertension: effects of protein kinase modulation in platelets. J Hypertens. 1991;9:1013-1019. [Medline] [Order article via Infotrieve]
14. Lortet S, Heckmann M, Aussedat J, Ray A, Vincent M, Sassard J, Zimmer HG, Rossi A. Alteration of cardiac energy state during development of the Lyon strain: a 31P-NMR study on the isolated rat heart. Acta Physiol Scand. 1993;149:311-312. [Medline] [Order article via Infotrieve]
15.
Aufferman W, Wu ST, Derugin N, Parmley W, Higgins C,
Kapelko V, Wikman-Cofflet J. 31P Magnetic resonance
spectroscopy of pressure overload hypertrophy in rats:
effect of reduced perfusion pressure. Cardiovasc
Res. 1990;24:57-64.
16. Buñag RA. Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol. 1973;34(2):279-282.
17. Camilión de Hurtado MC, Pérez NG, Cingolani HE. An electrogenic sodium-bicarbonate cotransport in the regulation of myocardial intracellular pH. J Mol Cell Cardiol. 1995;27:231-242. [Medline] [Order article via Infotrieve]
18.
Borzak S, Kelly RA, Kramer BK, Matoba Y, Marsh JD,
Reers M. In situ calibration of fura-2 and BCECF
fluorescence in adult rat ventricular
myocytes. Am J Physiol. 1990;259:H973-H981.
19. Bond JM, Chacon E, Herman B, Lemasters JJ. Intracellular pH and Ca2+ homeostasis in the pH paradox of reperfusion injury to neonatal rat cardiac myocytes. Am J Physiol. 1993;265(Cell Physiol 34):C129-C137.
20. Wang X, Levi AJ, Halestrap AP. Kinetics of the sarcolemmal lactate carrier in single heart cells using BCECF to measure pHi. Am J Physiol. 1994;267(Heart Circ Physiol 36):H1759-H1769.
21. Xu P, Spitzer KW. Na-independent Cl--HCO3- exchange mediates recovery of pHi from alkalosis in guinea pig ventricular myocytes. Am J Physiol. 1994;267(Heart Circ Physiol 36):H85-H91.
22.
Ross A, Boron WF. Intracellular pH.
Physiol Rev. 1981;61:296-434.
23. Brookes N, Turner RJ. K+-induced alkalinization in mouse cerebral astrocytes mediated by reversal of electrogenic Na+-HCO3- cotransport. Am J Physiol. 1994;267(Cell Physiol 36):C1633-C1640.
24.
Thomas RC. The effect of carbon dioxide on
the intracellular pH and buffering power of snail neurones.
J Physiol (Lond). 1976;255:715-735.
25. Vanheel B, de Hemptinne A, Leusen I. Influence of surface pH on intracellular pH regulation in cardiac and skeletal muscle. Am J Physiol. 1986;250(Cell Physiol 19):C748-760.
26.
Aikin CC. Direct measurements of intracellular
pH and buffering power in smooth muscle cells of guinea-pig vas
deferens. J Physiol (Lond). 1984;349:571-585.
27.
Bountra C, Powell T, Vaughan Jones RD.
Comparison of intracellular pH transients in single
ventricular myocytes and isolated ventricular
muscle of guinea-pig. J Physiol
(Lond). 1990;424:343-365.
28.
Vaughan Jones RD, Wu ML. pH dependence of
intrinsic H+ buffering power in the sheep cardiac Purkinje
fibre. J Physiol (Lond). 1990;425:429-448.
29. Wallert MA, Frölich O. Na+/H+ exchange in isolated myocytes from adult rat heart. Am J Physiol. 1989;257(Cell Physiol 26):C207-C213.
30. Lazdunski M, Frelin C, Vigne P. The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol. 1985;17:1029-1042. [Medline] [Order article via Infotrieve]
31.
Vandenberg JI, Metcalfe JC, Grace AA. Mechanisms
of pHi recovery after global ischemia in the
perfused heart. Circ Res. 1993;72:993-1003.
32.
Wu M-L, Tsai M-L, Tseng Y-Z. DIDS-sensitive
pHi regulation in single rat cardiac myocytes in nominally
HCO3-free conditions. Circ
Res. 1994;75:123-132.
33. Vaughan-Jones RD. Choride-bicarbonate exchange in sheep cardiac Purkinje fibre. In: Intracellular pH, Its Measurements, Regulation and Implications in Cellular Function. New York, NY: Alan R Liss Inc; 1982:239-252.
34. Grinstein S, Rotin D, Mason M. Na+/H+ exchange and growth factor-induced cytosolic pH changes: role in cellular proliferation. Biochim Biophys Acta. 1989;988:73-97. [Medline] [Order article via Infotrieve]
35.
Sardet C, Counillon L, Franchi A, Pouysségur
J. Growth factors induce phosphorylation of the
Na+/H+ antiporter, a
glycoprotein of 110kD. Science. 1990;247:723-726.
36.
Postnov YV, Orlov SN. Ion transport across
plasma membrane in primary hypertension. Physiol
Rev. 1985;65:904-945.
37. Blaustein MP. Physiological effects of endogenous ouabain: control of intracellular Ca2+ stores and cell responsiveness. Am J Physiol. 1993;264(Cell Physiol 33):C1367-C1387.
38.
Marban E, Koretsune Y. Cell calcium, oncogenes
and hypertrophy. Hypertension. 1990;15:652-658.
39. Dudley CRK, Taylor DJ, Ng LL, Kemp GJ, Ratcliffe PJ, Radda GK, Ledingham JGG. Evidence for abnormal Na+/H+ antiport activity detected by phosphorus nuclear magnetic resonance spectroscopy in exercising skeletal muscle from patients with essential hypertension. Clin Sci. 1990;79:491-497. [Medline] [Order article via Infotrieve]
40. Syme PD, Arnolda L, Green Y, Aronson JK, Grahame-Smith DG, Radda GK. Evidence for increased in vivo Na+/H+ antiporter activity and an altered skeletal muscle contractile response in the spontaneously hypertensive rat. J Hypertens. 1990;8:1027-1036. [Medline] [Order article via Infotrieve]
41. Siczkowski M, Davies JE, Ng LL. Sodium-hydrogen antiporter in normotensive Wistar-Kyoto rats and spontaneously hypertensive rats. J Hypertens. 1994,12:775-781.
42. Hoffmann G, Ko Y, Sachinidis A, Göbel BO, Vetter H, Rosskopf D, Siffert W, Düsing R. Kinetics of Na+/H+ exchange in vascular smooth muscle cells from WKY and SHR: effects of phorbol ester. Am J Physiol. 1995;268(Cell Physiol 37):C14-C20.
43. Aviv A. The link between cytosolic Ca2+ and the Na+/H+ antiport: a unifying factor for essential hypertension. J Hypertens. 1988;6:685-691. [Medline] [Order article via Infotrieve]
44. Aviv A, Livne A. The Na+/H+ antiport, cytosolic free Ca2+, and essential hypertension: a hypothesis. Am J Hypertens. 1988;1:410-413. [Medline] [Order article via Infotrieve]
45.
Kimura M, Gardner JP, Aviv A. Agonist-evoked
alkaline shift in the cytosolic pH set point for activation of
Na+/H+ antiport in human platelets:
the role of cytosolic Ca2+ and protein kinase
C. J Biol Chem. 1990;265:21068-21074.
46.
Berk BC, Aronow MS, Brock TA, Cragoe E, Gimbrone MA,
Alexander RW. Angiotensin II-stimulated
Na+/H+ exchange in cultured vascular
smooth cells. J Biol Chem. 1987;262:5057-5064.
47. Morishita R, Gibbons GH, Ellison KE, Zhang L, Kaneda Y, Ogihara T, Dzan VJ. Autocrine, paracrine renin angiotensin as a determinant of vascular structure: a gene transfer approach experiment. Hypertension. 1993;22:423. Abstract.
48. Cruickshank JM. Left ventricular hypertrophy reversibility with antihypertensive agents. In: Cruickshank JM, Messerli FH, eds. Left Ventricular Hypertrophy and Its Regression. London, UK: Science Press Ltd; 1992:71-80.
49. Cabantchik ZI, Rothstein A. Membrane proteins related to anion permeability of human red blood cells, I: localization of disulfonic stilbene binding sites in proteins involved in permeation. J Membr Biol. 1974;15:207-226. [Medline] [Order article via Infotrieve]
50.
Alonso A, Arrázola A, Garciandía A,
Esparza N, Gómez-Alamillo C, Díez J. Erythrocyte
anion exchanger activity and intracellular pH in essential
hypertension. Hypertension. 1993;22:348-356.
This article has been cited by other articles:
![]() |
J. R. Casey, W. S. Sly, G. N. Shah, and B. V. Alvarez Bicarbonate homeostasis in excitable tissues: role of AE3 Cl-/HCOFormula exchanger and carbonic anhydrase XIV interaction Am J Physiol Cell Physiol, November 1, 2009; 297(5): 1091 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Garciarena, C. I. Caldiz, E. L. Portiansky, G. E. Chiappe de Cingolani, and I. L. Ennis Chronic NHE-1 blockade induces an antiapoptotic effect in the hypertrophied heart J Appl Physiol, April 1, 2009; 106(4): 1325 - 1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Y. Nakamura, Y. Iwata, Y. Arai, K. Komamura, and S. Wakabayashi Activation of Na+/H+ Exchanger 1 Is Sufficient to Generate Ca2+ Signals That Induce Cardiac Hypertrophy and Heart Failure Circ. Res., October 10, 2008; 103(8): 891 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Perez, M. R. Piaggio, I. L. Ennis, C. D. Garciarena, C. Morales, E. M. Escudero, O. H. Cingolani, G. Chiappe de Cingolani, X.-P. Yang, and H. E. Cingolani Phosphodiesterase 5A Inhibition Induces Na+/H+ Exchanger Blockade and Protection Against Myocardial Infarction Hypertension, May 1, 2007; 49(5): 1095 - 1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Cingolani and I. L. Ennis Sodium-Hydrogen Exchanger, Cardiac Overload, and Myocardial Hypertrophy Circulation, March 6, 2007; 115(9): 1090 - 1100. [Full Text] [PDF] |
||||
![]() |
B. V. Alvarez, D. M. Kieller, A. L. Quon, M. Robertson, and J. R. Casey Cardiac hypertrophy in anion exchanger 1-null mutant mice with severe hemolytic anemia Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1301 - H1312. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. V. Alvarez, D. E. Johnson, D. Sowah, D. Soliman, P. E. Light, Y. Xia, M. Karmazyn, and J. R. Casey Carbonic anhydrase inhibition prevents and reverts cardiomyocyte hypertrophy J. Physiol., February 15, 2007; 579(1): 127 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kilic, A. Velic, L. J. De Windt, L. Fabritz, M. Voss, D. Mitko, M. Zwiener, H. A. Baba, M. van Eickels, E. Schlatter, et al. Enhanced Activity of the Myocardial Na+/H+ Exchanger NHE-1 Contributes to Cardiac Remodeling in Atrial Natriuretic Peptide Receptor-Deficient Mice Circulation, October 11, 2005; 112(15): 2307 - 2317. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. V Alvarez, D. M Kieller, A. L Quon, D. Markovich, and J. R Casey Slc26a6: a cardiac chloride-hydroxyl exchanger and predominant chloride-bicarbonate exchanger of the mouse heart J. Physiol., December 15, 2004; 561(3): 721 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fransen, R. R Lamberts, J. Hendrickx, and G. W De Keulenaer Endocardial endothelium modulates subendocardial pHi of rabbit papillary muscles: role of transendothelial HCO3- transport Cardiovasc Res, September 1, 2004; 63(4): 700 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pedrosa, P. A. Jose, and P. Soares-da-Silva Defective D1-like receptor-mediated inhibition of the Cl-/HCO3- exchanger in immortalized SHR proximal tubular epithelial cells Am J Physiol Renal Physiol, June 1, 2004; 286(6): F1120 - F1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. L. Ennis, E. M. Escudero, G. M. Console, G. Camihort, C. G. Dumm, R. W. Seidler, M. C. Camilion de Hurtado, and H. E. Cingolani Regression of Isoproterenol-Induced Cardiac Hypertrophy by Na+/H+ Exchanger Inhibition Hypertension, June 1, 2003; 41(6): 1324 - 1329. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M Pogwizd, K. R Sipido, F. Verdonck, and D. M Bers Intracellular Na in animal models of hypertrophy and heart failure: contractile function and arrhythmogenesis Cardiovasc Res, March 15, 2003; 57(4): 887 - 896. [Full Text] [PDF] |
||||
![]() |
M. I Bak and J. S Ingwall Contribution of Na+/H+ exchange to Na+ overload in the ischemic hypertrophied hyperthyroid rat heart Cardiovasc Res, March 15, 2003; 57(4): 1004 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, B. Alvarez, J. R. Casey, R. A. F. Reithmeier, and L. Fliegel Carbonic Anhydrase II Binds to and Enhances Activity of the Na+/H+ Exchanger J. Biol. Chem., September 20, 2002; 277(39): 36085 - 36091. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Cingolani and M. C. Camilion de Hurtado Na+-H+ Exchanger Inhibition: A New Antihypertrophic Tool Circ. Res., April 19, 2002; 90(7): 751 - 753. [Full Text] [PDF] |
||||
![]() |
S. Engelhardt, L. Hein, U. Keller, K. Klambt, and M. J. Lohse Inhibition of Na+-H+ Exchange Prevents Hypertrophy, Fibrosis, and Heart Failure in {beta}1-Adrenergic Receptor Transgenic Mice Circ. Res., April 19, 2002; 90(7): 814 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Camilion de Hurtado, E. L. Portiansky, N. G. Perez, O. R. Rebolledo, and H. E. Cingolani Regression of cardiomyocyte hypertrophy in SHR following chronic inhibition of the Na+/H+ exchanger Cardiovasc Res, March 1, 2002; 53(4): 862 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chiappe de Cingolani, P. Morgan, C. Mundina-Weilenmann, J. Casey, J. Fujinaga, M. Camilion de Hurtado, and H. Cingolani Hyperactivity and altered mRNA isoform expression of the Cl-/HCO3- anion-exchanger in the hypertrophied myocardium Cardiovasc Res, July 1, 2001; 51(1): 71 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. C. de Hurtado, B. V. Alvarez, I. L. Ennis, and H. E. Cingolani Stimulation of Myocardial Na+-Independent Cl--HCO3- Exchanger by Angiotensin II Is Mediated by Endogenous Endothelin Circ. Res., March 31, 2000; 86(6): 622 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wolk Arrhythmogenic mechanisms in left ventricular hypertrophy Europace, January 1, 2000; 2(3): 216 - 223. [Abstract] [PDF] |
||||
![]() |
H. E. Cingolani Na+/H+ exchange hyperactivity and myocardial hypertrophy: Are they linked phenomena? Cardiovasc Res, December 1, 1999; 44(3): 462 - 467. [Full Text] [PDF] |
||||
![]() |
B. V. Alvarez, N. G. Perez, I. L. Ennis, M. C. Camilion de Hurtado, and H. E. Cingolani Mechanisms Underlying the Increase in Force and Ca2+ Transient That Follow Stretch of Cardiac Muscle : A Possible Explanation of the Anrep Effect Circ. Res., October 15, 1999; 85(8): 716 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Skolnick, S. E. Litwin, W. H. Barry, and K. W. Spitzer Effect of ANG II on pHi, [Ca2+]i, and contraction in rabbit ventricular myocytes from infarcted hearts Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1788 - H1797. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. L. Ennis, B. V. Alvarez, M. C. C. de Hurtado, and H. E. Cingolani Enalapril Induces Regression of Cardiac Hypertrophy and Normalization of pHi Regulatory Mechanisms Hypertension, April 1, 1998; 31(4): 961 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. C. de Hurtado, B. V. Alvarez, N. G. Perez, I. L. Ennis, and H. E. Cingolani Angiotensin II Activates Na+-Independent Cl--HCO3- Exchange in Ventricular Myocardium Circ. Res., March 9, 1998; 82(4): 473 - 481. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Brosius III, R. L. Pisoni, X. Cao, G. Deshmukh, D. Yannoukakos, Alan. K. Stuart-Tilley, C. Haller, and S. L. Alper AE anion exchanger mRNA and protein expression in vascular smooth muscle cells, aorta, and renal microvessels Am J Physiol Renal Physiol, December 1, 1997; 273(6): F1039 - F1047. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Gende Chelerythrine Inhibits Na+-H+ Exchange in Platelets From Spontaneously Hypertensive Rats Hypertension, December 1, 1996; 28(6): 1013 - 1017. [Abstract] [Full Text] |
||||
![]() |
B. V. Alvarez, J. Fujinaga, and J. R. Casey Molecular Basis for Angiotensin II-Induced Increase of Chloride/Bicarbonate Exchange in the Myocardium Circ. Res., December 7, 2001; 89(12): 1246 - 1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Engelhardt, L. Hein, U. Keller, K. Klambt, and M. J. Lohse Inhibition of Na+-H+ Exchange Prevents Hypertrophy, Fibrosis, and Heart Failure in {beta}1-Adrenergic Receptor Transgenic Mice Circ. Res., April 19, 2002; 90(7): 814 - 819. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |